首页> 美国卫生研究院文献>Infection and Immunity >Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6
【2h】

Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6

机译:基于抗原85B和ESAT-6融合蛋白的结核亚单位疫苗对小鼠的保护

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, we investigated the potential of a tuberculosis subunit vaccine based on fusion proteins of the immunodominant antigens ESAT-6 and antigen 85B. When the fusion proteins were administered to mice in the adjuvant combination dimethyl dioctadecylammonium bromide-monophosphoryl lipid A, a strong dose-dependent immune response was induced to both single components as well as to the fusion proteins. The immune response induced was accompanied by high levels of protective immunity and reached the level of Mycobacterium bovis BCG-induced protection over a broad dose range. The vaccine induced efficient immunological memory, which remained stable 30 weeks postvaccination.
机译:在这项研究中,我们研究了基于免疫优势抗原ESAT-6和抗原85B融合蛋白的结核亚单位疫苗的潜力。当将融合蛋白以佐剂组合的形式给予溴化二甲基二十八烷基溴化铵-单磷酰基脂质A时,对单个组分以及对融合蛋白均诱导了强烈的剂量依赖性免疫应答。诱导的免疫反应伴随着高水平的保护性免疫,并在很宽的剂量范围内达到了牛分枝杆菌BCG诱导的保护水平。疫苗诱导了有效的免疫记忆,接种后30周保持稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号